Literature DB >> 19903067

Etiologic factors in testicular germ-cell tumors.

Katherine A McGlynn1, Michael B Cook.   

Abstract

Globally, testicular cancer incidence is highest among men of northern European ancestry and lowest among men of Asian and African descent. Incidence rates have been increasing around the world for at least 50 years, but mortality rates, at least in developed countries, have been declining. While reasons for the decreases in mortality are related to improvements in therapeutic regimens introduced in the late 1970s, reasons for the increase in incidence are less well understood. However, an accumulating body of evidence suggests that testicular cancer arises in fetal life. Perinatal factors, including exposure to endocrine-disrupting chemicals, have been suggested to be related to risk.

Entities:  

Mesh:

Year:  2009        PMID: 19903067      PMCID: PMC3000220          DOI: 10.2217/fon.09.116

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  196 in total

1.  Body size at birth and adulthood and the risk for germ-cell testicular cancer.

Authors:  Lorenzo Richiardi; Johan Askling; Fredrik Granath; Olof Akre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-07       Impact factor: 4.254

2.  Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?

Authors:  M J Khoury; T H Beaty; K Y Liang
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

3.  Risk factors for cancer of the testis in young men.

Authors:  B E Henderson; B Benton; J Jing; M C Yu; M C Pike
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

4.  AIDS related neoplasms in Genoa, Italy.

Authors:  G Gabutti; M Vercelli; M G De Rosa; M A Orengo; C Casella; E Garrone; C Orlandini; N Piersantelli; A Torresin; F Rizzo
Journal:  Eur J Epidemiol       Date:  1995-12       Impact factor: 8.082

Review 5.  Lessons learned from perinatal exposure to diethylstilbestrol.

Authors:  Retha R Newbold
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-01       Impact factor: 4.219

Review 6.  The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature.

Authors:  K P Dieckmann; U Pichlmeier
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

7.  Trends in incidence of testicular cancer in Norway 1955-1992.

Authors:  E H Wanderås; S Tretli; S D Fosså
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

8.  Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives' records in Denmark.

Authors:  S Sabroe; J Olsen
Journal:  Int J Cancer       Date:  1998-10-05       Impact factor: 7.396

9.  Maternal and neonatal risk factors for cryptorchidism.

Authors:  G S Berkowitz; R H Lapinski; J H Godbold; S E Dolgin; I R Holzman
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

10.  Testicular cancer risk and maternal parity: a population-based cohort study.

Authors:  T Westergaard; P K Andersen; J B Pedersen; M Frisch; J H Olsen; M Melbye
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more
  62 in total

1.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

2.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

3.  Testicular cancer: changing patterns of incidence in testicular germ cell tumours.

Authors:  Mausam Singhera; Robert Huddart
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

4.  A stratified genetic risk assessment for testicular cancer.

Authors:  C P Kratz; M H Greene; G Bratslavsky; J Shi
Journal:  Int J Androl       Date:  2011-05-12

Review 5.  Germline genome protection: implications for gamete quality and germ cell tumorigenesis.

Authors:  J C Bloom; A R Loehr; J C Schimenti; R S Weiss
Journal:  Andrology       Date:  2019-05-22       Impact factor: 3.842

6.  Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer.

Authors:  Timothy M Pierpont; Amy M Lyndaker; Claire M Anderson; Qiming Jin; Elizabeth S Moore; Jamie L Roden; Alicia Braxton; Lina Bagepalli; Nandita Kataria; Hilary Zhaoxu Hu; Jason Garness; Matthew S Cook; Blanche Capel; Donald H Schlafer; Teresa Southard; Robert S Weiss
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

7.  Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.

Authors:  Delphine Carouge; Valerie Blanc; Sue E Knoblaugh; Robert J Hunter; Nicholas O Davidson; Joseph H Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

Review 8.  Testicular germ cell tumor genomics.

Authors:  Solomon L Woldu; James F Amatruda; Aditya Bagrodia
Journal:  Curr Opin Urol       Date:  2017-01       Impact factor: 2.309

9.  Molecular genetics of testicular germ cell tumors.

Authors:  Yuri Sheikine; Elizabeth Genega; Jonathan Melamed; Peng Lee; Victor E Reuter; Huihui Ye
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

10.  Incidence of testicular germ cell tumors among US men by census region.

Authors:  Armen A Ghazarian; Britton Trabert; Barry I Graubard; Stephen M Schwartz; Sean F Altekruse; Katherine A McGlynn
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.